| Active Pharmaceutical Ingredients (API) | Manufacture and supply of APIs primarily for regulated international markets including US, Europe, and Brazil. | USFDA-approved facilities, multiple DMFs/CEPs, diverse regulatory approvals, backward integration capabilities. | Pharmaceutical companies globally; B2B focus with exports to 50+ countries. | High-value APIs with significant global market share such as Sertraline and Metformin. | 53000 | 88 | Revenue through direct sales and long-term supply contracts. | Contract and direct sales based on volume and market rates. | Pipeline molecule launches, capacity debottlenecking, expanding regulated market approvals. | Metformin, Sertraline, Tramadol, Paroxetine, Mefenamic Acid, Diphenhydramine |
| Formulations | Branded pharmaceutical formulations in acute and semi-chronic categories targeting Indian market. | Established brand heritage, extensive distribution, and focused marketing strategy. | Retail pharmacies, hospitals, doctors across India; B2C and B2B via distributors. | Specialty therapies and chronic care brands. | 7000 | 12 | Revenue from product sales through extensive distribution and marketing network. | Direct sales with focus on brand building and doctor engagement. | New product launches, geographic expansion, increased field force strength. | Cdense Gems, Myotol-F, Folinine, Cal-K2 and other branded therapeutics |
